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Dioxin: Reassessing the Risk*
Linda-Jo Schierow**
Summary
For over 25 years, scientists have studied dioxin, a potent animal
carcinogen. Yet opinions remain divided with regard to its human
health risk. Based on new data, the Environmental Protection Agency
(EPA) has been updating its assessment of dioxin risk since 1991. In
December 1994, EPA submitted for review a final draft report to its
Science Advisory Board (SAB), a group of independent experts. Several
months later, the news media reported -highly critical comments by
some SAB members, raising concerns among those who want to ensure
that EPA's decisions are based on sound science.
The SAB completed its review last September and approved most
of the report. 1 However, it withheld approval of two chapters
pending extensive revisions.
The House Committee on Science held a hearing on the dioxin
reassessment December 13, 1995, and the House and Senate
Committees on Appropriations have directed the agency to incorporate
SAB recommendations into its report.
This paper briefly describes the state of scientific knowledge about
dioxin, the reassessment project, the SAB review, scientific issues that
remain unresolved, EPA dioxin regulations under development and
recommendations of the Committees on Appropriations.
Background
Dioxin (2,3,7,8-tetrachlorodibenzodioxin or TCDD) is produced
in very small quantities as a by-product of combustion, some chemical
* Views expressed here are the author's and do not necessarily represent those of
the Congressional Resarch Service (CRS).
** Dr. Schierow is a Specialist in Environmental Policy in the Environment and
Natural Resources Policy Division, CRS. She received her B.S. (Education), M.S, and
Ph.D. (Land Resources) from the University of Wisconsin-Madison.
1 Environmental Protection Agency, Science Advisory Board (SAB), An SAB
Report. A Second Look at Dioxin (1995).
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manufacture, chlorine bleaching of pulp and paper, and other industrial
processes. In the U.S., municipal and medical waste incineration are
dominant known sources. Low levels have been found in many parts of
the world. Because of dioxin's physical and chemical properties, it is
found primarily in soil, sediments and biota (that is, living things).
Dioxin was identified in the 1970's as the most potent animal
carcinogen ever tested. Although further research has confirmed its
cancer-causing potential for all types of animals tested, some animals
are found less susceptible to dioxin's effects than others; for example,
males and females develop tumors at different sites and rates.
Studies of the number of people likely to get cancer from being
exposed to dioxin are inconclusive, in part because scientists could not
be certain how much dioxin they were exposed to. Also, they probably
were also exposed to diverse mixtures of chemicals. Further, in most
cases, the numbers of people exposed were too small to allow accurate
measurements of changes in cancer rates, those exposed were mostly
healthy adult males (who may be less sensitive), or not enough time had
passed for most cancers to develop. 2 Although scientists have
interpreted the significance of these studies in various ways, they
generally agree that human data are "limited," and dioxin is a
"probable" human carcinogen under some conditions of exposure. 3
Research also has shown that dioxin elicits many toxic responses
besides cancer; e.g., it is known to cause chloracne in highly exposed
people. Also, although further research is needed, evidence suggests that
it may affect levels of human male reproductive hormones. In various
test animals, dioxin and related compounds impair reproduction,
interfere with vitamin A storage, and adversely affect the immune
system and embryo development, among other things.
Without at least potential exposure, there is no risk. Yet, dioxin has
been found in tissue samples taken from people living in the U.S. -
probably originating mainly from foods, especially meat and fish.
Whether exposure from such sources is high enough to harm health is
unknown, but currently EPA is gathering more data to integrate into its
final dioxin risk reassessment report.
2 Most cancers develop 15 to 30 years after exposure. See e.g., Judith S. Mausner
& Shira Kramer, Epidemiologyr An Introductory Text 320 (2d Ed. 1985).
3 SAB, supra note 2, at 4.
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Notwithstanding scientific uncertainties, EPA has regulated dioxin
emissions to protect public health and the environment. Some EPA
critics charge that existing and proposed regulations are too stringent
given the available scientific evidence, but others argue for additional
limits and have called for phasing out all production and use of
chlorinated organic compounds that do not readily degrade to
harmless substances.
EPA's Reassessment Project
EPA completed two risk assessments for dioxin in 1985 and 1988.
Stakeholders have carefully observed and often participated. The 1985
assessment led EPA to classify dioxin as a probable human carcinogen
based on adequate animal data. After reviewing the 1988 risk
assessment, the SAB concluded that EPA should "follow up on this
excellent start" by developing new methods for estimating human
exposure to dioxin and relating exposure levels to health risks. 4
Current dioxin reassessment responds to that request.
General scientific interest in the project was spurred by evidence
published during the early 1990's that fueled long-standing
controversies. Several published scientific studies of people exposed to
dioxin failed clearly to document large increases in cancer rates. This
convinced some scientists that people might be less sensitive to dioxin
than some test animals. Others argued that new human data were
consistent with animal data, given exposure levels. The former group of
scientists also interpreted new knowledge about how dioxin affects cells
to mean that very low levels of exposure to dioxin might be harmless or
even beneficial; they wanted this reflected in EPA cancer risk
assessment models. Again, other scientists disagreed.
However, when scientists representing a full range of opinions met
in 1990 at the Banbury Center of Cold Spring Harbor Laboratory, they
agreed that evidence now supports the following conclusions: 5
4 SAB, Resolution on the Use of Mathematical Models by EPA for Regulatory
Assessment and Decision-Making (1989).
5 See Biological Basis for Risk Assessment of Dioxins and Related Compounds,
Banbury Report No. 35, (Michael A. Gallo, Robert J. Scheuplein & Kees A. van der
Heijden eds. 1991).
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p eople and animals respond to dioxin in similar ways;
* other similar chemicals were likely to behave like dioxin;
and
* a new risk assessment model should be developed based
on cell biology.
EPA began in 1991 to reassess the risks of dioxin. The current risk
assessment differs from previous dioxin assessments in several ways. It:
* is a very public process, inviting observation and
comment from interest groups as well as scientists;
" addresses risks to the environment as well as to human
health;
* assesses risks from health effects other than cancer; and
* assesses risks of "related chemicals" as well as dioxin per
se.
"Related chemicals" are other compounds containing chlorine or
bromine whose molecules are shaped like TCDD and produce similar
toxic effects, including some other dioxin compounds, some furan
compounds, some polychlorinated biphenyls (PCBs), and some
polybrominated biphenyls (PBBs).
More than 100 outside scientists have participated over four years in
the EPA project, attending workshops and public meetings, drafting
and reviewing portions of the EPA report and performing laboratory
research. EPA's draft report on the ecological risks of TCDD and
related chemicals is expected to be completed next year. A draft final
report on human health risks was released for public review and
comment September 13, 19946 and was submitted to the SAB for
review in December.7
SAB Review
The SAB appointed 39 scientists to a committee which met in May
1995 to review the draft dioxin assessment. Many news reports of this
meeting emphasized critical comments and challenged the science
employed by the EPA draft; at least one Op Ed piece concluded that
EPA's research was policy or politically driven.8 This alarmed many
who are concerned about whether EPA's decisions are based on sound
6 59 Fed. Reg. 46980.
7 The draft is not a statement of EPA findings or policy because it is not complete;
it was released to elicit public comment and has not been approved by EPA officials.
8 Kathryn E. Kelly, Cleaning up EPA s Dioxin Mess, Wall Street Journal, June 29,
1995, at 16.
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science. SAB Chair, Morton Lippmann, responded to this charge by
calling it "misguided and misleading," 9 while the EPA Assistant
Administrator for Research and Development argued that:10
the dioxin assessment has been exemplary of an open and
participatory scientific process, involving hundreds of
scientists from outside of the agency.
The SAB Executive Committee did not complete its review until
September. 1 1 The final SAB report approved EPA's exposure
assessment chapters and the first seven chapters of the health assessment
with relatively minor changes. The Committee withheld endorsement
of Chapter 8 pending revisions. Specifically, the SAB criticized EPA's
reliance on a single dose-response model for estimating cancer risk and
advised discussing reasonable alternative models that posit little increase
in risk at very low levels of dioxin exposure. The SAB also advised EPA
to note that TCDD is not a complete carcinogen - that is, its effects
depend on other factors. However, almost all SAB members agree that
TCDD is likely to increase cancer incidence under some exposure
conditions. 12 Chapter 9 of the health assessment summarizes the
previous chapters and characterizes the risk. The SAB also withheld
endorsement of this chapter, although it noted three strengths:
* evaluating a group of compound classes, rather than a
single compound;
* focusing attention on various non-cancer effects; and
* providing a useful comparative perspective by
highlighting the fact that the margin of safety (between
background exposures and levels of exposure where
effects have been observed in test animals) for dioxin-
like compounds is smaller than that EPA usually accepts
for many other compounds.
9 Letter submitted to Editor, Wall Street Journal, printed in the SAB newsletter,
Happenings, July 1995, at 4.
10 Robert J. Huggett, Letter to the Editor, Wall Street Journal, July 19, 1995, at A-
13.
11 SAB, supra note 1.
12 The SAB, supra note 1, reports, at 4:
One Member contends that no epidemiological study has produced
evidence that is widely accepted by the scientific community, including
the International Agency for Research on Cancer, as being convincing
for the human carcinogenicity of dioxin.
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However, the SAB urged additional external peer review of the
chapter and identified three key weaknesses: 13
" not describing non-cancer risks in a way that can
facilitate meaningful analysis of the incremental benefits
of management options;
* not fully identifying and analyzing important
uncertainties; and
" tending to overstate the possibility for danger.
EPA will revise its report in response to the SAB comments. The
agency expects the revision to take at least a year.
Current Issues
When risk assessments evaluate the potential for harm of toxic
substances, a purely scientific prediction is impossible, because there are
too few data or theories are not well validated. To fill these gaps,
scientists must use their own judgments which often are controversial
because different scientists make different judgments leading to
different risk estimates which may have strong implications for
regulatory policies and impacts on various stakeholders. Such
controversies are inherent in most risk assessments but have been
especially vigorous in the dioxin reassessment project that is apparently
particularly important to scientists and policy makers. In part the issue's
importance and the vigor of the debate may be due to the
groundbreaking nature of the project (i.e., EPA's attempt to assess risks
for health effects other than cancer as well as risks of groups of related
chemicals) or to the difficulty of analyzing health risks for a compound
that affects poorly understood and complex biological processes
including immune responses and reproduction. Moreover, the
fundamental nature of the scientific questions involved in the dioxin
risk assessment means that some scientists are heavily invested
intellectually and professionally in their points of view. Timing of the
reassessment also may affect its perceived importance: The EPA draft
report was issued just as Congress began debating whether to endorse
specified principles of risk assessment and risk characterization. For
13 The SAB, supra note 1, reports, at 5:
several SAB Members do not agree with this statement and regard the
EPA presentation as appropriately conservative within the context of
public health protection.
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EPA, the dioxin reassessment report is an opportunity to demonstrate
its competence and the evolution of its risk assessment practices.
Thus, although scientists working on the project could agree on how
to describe experimental evidence relevant to dioxin exposure and
toxicity in the earlier chapters of the draft final report, they are still
struggling to summarize and interpret the objective evidence to
construct models and characterize risk. Similarly, although the SAB
report attempted to present a single scientific viewpoint with regard to
its assessment of dioxin risk and the EPA draft, occasional footnotes
indicate intransigent areas of disagreement. 14
Key unresolved scientific issues relevant to decisions of risk
managers and policy makers include whether:
* there is a low level of exposure to dioxin that is harmless
(that is, whether there is a threshold);
" current exposures to dioxin-like compounds in the U.S.
are likely to be harmful to adults or children; and
" all the most important sources of dioxin emissions and
human exposure are known.
None of these questions are expected to be answered definitively in the
EPA final document.
In the face of such uncertainty, the agency must implement
environmental statutes, and it is currently developing several regulations
regarding technologies that are likely to further limit dioxin emissions.
For example, the Clean Air Act, as amended, requires EPA to
promulgate performance standards, including emission standards, for
large municipal waste incinerators and medical waste incinerators by
November 1991 and November 1992, respectively. When these
deadlines were missed, EPA was sued by the Sierra Club and Natural
Resources Defense Council. Under a consent decree, EPA is required to
issue a final rule for municipal waste incinerators by October 31,
1995.15 A final rule for medical waste incinerators is expected by April
1996. Both the Clean Air Act and the Solid Waste Disposal Act auth-
orize EPA regulation of pollutant emissions from incinerators, kilns,
other industrial furnaces and boilers that burn hazardous waste. A
settlement agreement 16 requires EPA to propose combustion stan-
14 See, e.g., supra notes 12 & 13.
15 NRDC v. EPA, Nos. CV-92-2093 and CV-93-028 (E. D.N.Y 1994).
16 Horsehead Resource Development Co. Inc. v. EPA, No. 91-1221 (Oct. 22,
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dards by September 20, 1995 and promulgate a rule by December 15,
1996. (An informal agreement has extended the 1995 deadline for two
months.) Both the Clean Air Act and the Clean Water Act require
regulation of pollutant releases from major industrial sources. EPA has
designated the pulp and paper industry a "major source" of hazardous
air pollutants, including dioxin. A combined air and water rule
addressing pollutant releases was proposed December 17, 1993. EPA
plans to issue the final rule no earlier than this winter.
House Appropriations Committee Recommendations
In House and Senate reports on the FY 1996 appropriations bill,
H.R. 2099, the Appropriations Committees expressed concern that the
EPA draft dioxin risk characterization document: 17
does not accurately reflect the science on exposures to
dioxins and their potential health effects... [,] EPA selected
and presented scientific data and interpretations...
dependent upon assumptions and hypotheses that deserve
careful scrutiny... [,] and inaccuracies and omissions... were
the result of the Agency's failure to consult with and utilize
the assistance of the outside scientific community....
Thus, the Committees propose directing EPA to respond to SAB
concerns about its report and to consult with scientists in other agencies
in rewriting chapters 8 and 9. -The House Committee also directed
EPA to report back on compliance within 90 days of enactment of
H.R. 2099 [subsequently vetoed] and to report to Congress prior to
spending any funds "on further advancing the reassessment of any rules
using the reassessment as a basis." This restriction, if enacted, might
prevent EPA from developing any new rules that raise or lower dioxin
limits based on the risk reassessment. Yet, it apparently would have no
affect on the development of such rules as long as they were not so
based.
1993).
17 H. Rept. 104-201, at 53-4; Senate Rept. 104-40, at 89.
